Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery

• Main Authors: Hausenloy, D.J, Barrabes, J.A, Bøtker, H.E, Davidson, S.M, Di Lisa, F, Downey, J, Engstrom, T, Ferdinandy, P, Carbrera-Fuentes, H.A, Heusch, G, Ibanez, B, Iliodromitis, E.K, Inserte, J, Jennings, R, Kalia, N, Kharbanda, R, Lecour, S, Marber, M, Miura, T, Ovize, M, Perez-Pinzon, M.A, Piper, H.M, Przyklenk, K, Schmidt, M.R, Redington, A, Ruiz-Meana, M, Vilahur, G, Vinten-Johansen, J, Yellon, D.M, Garcia-Dorado, D
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Published: Dr. Dietrich Steinkopff Verlag GmbH and Co. KG 2020
• Subjects: cariporide; cyclosporin A; exendin 4; glucagon like peptide 1; glucagon like peptide 1 derivative; glyceryl trinitrate; high density lipoprotein; melatonin; metoprolol; mitogen activated protein kinase 1; mitogen activated protein kinase 3; protein kinase B; purinergic P2Y12 receptor; purinergic receptor blocking agent; combination drug therapy; drug targeting; heart infarction prevention; heart muscle reperfusion; heart protection; human; ischemic postconditioning; ischemic preconditioning; mitochondrion; myocardial ischemia reperfusion injury; nonhuman; protein function; randomized controlled trial (topic); remote ischemic conditioning; remote ischemic preconditioning; Review; second window of protection; signal transduction; ST segment elevation myocardial infarction; therapy effect; translational research; animal; Animals; Humans; Ischemic Preconditioning, Myocardial; Myocardial Reperfusion Injury
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/175244
• Institution: National University of Singapore

10.1007/s00395-016-0588-8